Jazz Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) will webcast its corporate presentation at the 41st Annual J.P. Morgan Healthcare Conference on January 9, 2023, at 3:45 p.m. PST / 11:45 p.m. GMT. CEO Bruce Cozadd will discuss the company's business and financial updates. Investors can access the live audio via Jazz Pharmaceuticals' website, with a replay available for 30 days post-conference. The company is committed to developing innovative medicines for patients with serious diseases across neuroscience and oncology, serving nearly 75 countries globally.

DUBLIN, Jan. 3, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will webcast its corporate presentation at the 41^st Annual J.P. Morgan Healthcare Conference. Bruce Cozadd, chairman and chief executive officer, will provide an overview of the company and a business and financial update on Monday, January 9, 2023, at 3:45 p.m. PST / 11:45 p.m. GMT.

A live audio webcast of the presentation may be accessed via the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. A replay of the webcast will be available on the website for 30 days following the conference.  

About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases—often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. Within these therapeutic areas, we are identifying new options for patients by actively exploring small molecules and biologics, and through innovative delivery technologies and cannabinoid science. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. For more information, please visit www.jazzpharmaceuticals.com for more information.

Contacts:

Investors:
Andrea N. Flynn, Ph.D.
Vice President, Head, Investor Relations
Jazz Pharmaceuticals plc
InvestorInfo@jazzpharma.com     
Ireland, +353 1 634 3211
U.S., +1 650 496 2717

Media:
Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc
CorporateAffairsMediaInfo@jazzpharma.com
Ireland, +353 1 637 2141
U.S., +1 215 867 4948

View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-present-at-the-41st-annual-jp-morgan-healthcare-conference-301712069.html

SOURCE Jazz Pharmaceuticals plc

FAQ

When will Jazz Pharmaceuticals present at the J.P. Morgan Healthcare Conference?

Jazz Pharmaceuticals will present on January 9, 2023, at 3:45 p.m. PST.

Who will present for Jazz Pharmaceuticals at the conference?

Bruce Cozadd, CEO of Jazz Pharmaceuticals, will make the presentation.

How can I access the Jazz Pharmaceuticals conference webcast?

The webcast can be accessed via the Investors section of the Jazz Pharmaceuticals website.

What is the duration of the webcast replay for Jazz Pharmaceuticals?

The replay of the webcast will be available for 30 days after the conference.

What therapeutic areas does Jazz Pharmaceuticals focus on?

Jazz Pharmaceuticals develops medicines primarily in neuroscience and oncology.